BWA logo

BWA

BorgWarner Inc.

$48.15
+$0.74(+1.56%)
78
Overall
100
Value
75
Tech
60
Quality
Market Cap
$9.61B
Volume
2.46M
52W Range
$24.40 - $49.21
Target Price
$50.08

Latest News for BWA

BlackRock Marginally Increases Stake in Austria’s BAWAG Group
TipRanks Germany Auto-Generated Newsdesk20 hours agoFeb 02, 2026

BAWAG Group AG ( ($DE:0B2) ) has issued an announcement. BAWAG Group AG has disclosed a change in its shareholder structure following a notificatio......

BlackRock Slightly Reduces Stake but Remains Major Shareholder in BAWAG Group
TipRanks Germany Auto-Generated Newsdesk5 days agoJan 29, 2026

An announcement from BAWAG Group AG ( ($DE:0B2) ) is now available. BlackRock, Inc. has notified BAWAG Group AG and the Austrian authorities that i......

BlackRock Adjusts Stake in BAWAG Group to 5.83% of Voting Rights
TipRanks Germany Auto-Generated Newsdesk12 days agoJan 22, 2026

BAWAG Group AG ( ($DE:0B2) ) has provided an announcement. BAWAG Group AG has disclosed a change in major shareholdings following a notification fr......

BrainsWay Wins Draft Highmark Coverage for Accelerated Deep TMS Depression Protocol
TipRanks Auto-Generated Newsdesk13 days agoJan 21, 2026

Brainsway ( ($BWAY) ) just unveiled an announcement. On January 21, 2026, BrainsWay announced that Highmark Blue Cross Blue Shield, which covers mo......

Kepler Capital Keeps Their Buy Rating on BAWAG Group AG (0B2)
TipRanks Auto-Generated Intelligence Newsdesk17 days agoJan 18, 2026

Kepler Capital analyst Tobias Lukesch maintained a Buy rating on BAWAG Group AG on January 16 and set a price target of €145.00. The company’s shar......

BAWAG Group launches EUR 75 million share buyback for stock programs
TipRanks Germany Auto-Generated Newsdesk21 days agoJan 13, 2026

BAWAG Group AG ( ($DE:0B2) ) has issued an announcement. BAWAG Group AG’s Management Board has approved a share buyback program of up to EUR 75 mil......

BrainsWay Highlights FDA Approval of Neurolief’s At-Home Proliv Rx Device for Treatment-Resistant Depression
TipRanks Auto-Generated Newsdesk22 days agoJan 12, 2026

An announcement from Brainsway ( ($BWAY) ) is now available. On January 12, 2026, BrainsWay Ltd. reported that the U.S. Food and Drug Administratio......

Piper Sandler downgrades BorgWarner (BWA) to a Hold
TipRanks Auto-Generated Intelligence Newsdeska month agoJan 08, 2026

BorgWarner received a Hold rating and a $51.00 price target from Piper Sandler analyst Alexander Potter today. Potter covers the Consumer Cyclical ......

BrainsWay Wins First Insurer Coverage for Accelerated Deep TMS Depression Protocol
TipRanks Auto-Generated Newsdeska month agoJan 07, 2026

Brainsway ( ($BWAY) ) just unveiled an announcement. On January 7, 2026, BrainsWay announced that Premera Blue Cross Blue Shield, which covers more......

News data is sourced from MarketXLS API and updated regularly.
Showing 9 of 9 articles.

ABCD
1SymbolPriceChangeVol
2BWA$48.15+1.6%2.46M
3
4
5
6

Get BorgWarner Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.